Pharmaceutisch Weekblad

, Volume 10, Issue 4, pp 145–150 | Cite as

Quality control of hospital formularies

  • T. Donald Rucker
Quality Control in Hospital Pharmacy


This paper identifies various uses of the formulary concept, outlines factors that underlie the need for such an administrative device, and reviews four barriers to effective formulary control. It then examines selected components of the formulary system and specifies the need for supporting techniques, both internal and external. Twelve guidelines for developing a model drug formulary are presented. While administrative elements associated with implementation of a formulary are stressed, concerns about more intangible behavioural forces are introduced.


Formularies, hospital Pharmacy and therapeutics committee Prescriptions, drugs Quality control 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Oslet J. Looking back to Helsinki. Int Pharm J 1987;1:126.Google Scholar
  2. 2.
    Rucker TD. The role of formularies and their relationship to drug product selection. In: Goldberg T, De Vito CA, Raskin IE, eds. Generic drug laws: a decade of trial —a prescription for progress. Washington: Public Health Service, National Center for Health Services Research, 1986:465–85.Google Scholar
  3. 3.
    Plumridge RJ, Stoelwinder JU, Berbatis CG. Improving patient care and pharmacy management: the effect of hospital formularies. Drug Intell Clin Pharm 1984;18:653.Google Scholar
  4. 4.
    Pellegrino ED. A physician appraises the formulary system. Hospitals 1905;39:78.Google Scholar
  5. 5.
    Quigley MA, Brown WM. A survey of selective administration procedures in formulary maintenance. Hosp Pharm 1981;16:371–80.Google Scholar
  6. 6.
    Brater DC. Dilemmas of formulary selection and restriction. Hosp Pharm 1986;21:633.Google Scholar
  7. 7.
    Muller C, Westheimer RE. Formularies and drug standards in metropolitan hospitals. Hospitals 1966;40:101.PubMedGoogle Scholar
  8. 8.
    Avorn J, Chen M, Hartley M. Scientific versus commercial sources of influence on the prescribing of physicians. Am J Med 1982;73:4–8.CrossRefGoogle Scholar
  9. 9.
    Anonymous. How do doctors learn about drugs? Lancet 1975;2:268.Google Scholar
  10. 10.
    Avorn J, Soumerai SB. Improving drug-therapy decisions through educational outreach. N Engl J Med 1983;308:1457–63.PubMedGoogle Scholar
  11. 11.
    Rucker TD. The top-selling drug products: how good are they? Am J Hosp Pharm 1980;37:836.Google Scholar
  12. 12.
    Ridley H. Drugs of choice — a report on drug formularies used in NHS hospitals. London: Social Audit, 1986.Google Scholar
  13. 13.
    Abramowitz PWW. Controlling financial variables — changing prescribers patterns. Am J Hosp Pharm 1984;41:503.PubMedGoogle Scholar
  14. 14.
    Rucker TD, Visconti JA. How effective are drug formularies? A descriptive and normative study. Washington: ASHP Research & Education Foundation, 1978.Google Scholar
  15. 15.
    Kelly WN. [Letter to the editor]. Hosp Pharm 1983; 18:135.Google Scholar
  16. 16.
    Green JA. Point: the formulary system and the emperor's new clothes. Am J Hosp Pharm 1986;43:2832.Google Scholar
  17. 17.
    Rucker TD. Problem solving: the professional responsibility of pharmacists. Drug Intell Clin Pharm 1986;20:556–60.PubMedGoogle Scholar
  18. 18.
    Pledger GW, Hall D. Active control trials: do they address the efficacy issue? In: Proceedings of the Biopharmaceutical Section, American Statistical Association, Alexandria. Washington: American Statistical Association, 1986:1–8.Google Scholar
  19. 19.
    Talley CR. Hospitals defend decisions against industry attacks. Am J Hosp Pharm 1978;35:1154–5.PubMedGoogle Scholar
  20. 20.
    Anonymous. [Letter to the editor]. Hosp Pharm 1983;18:142.Google Scholar
  21. 21.
    Abramowitz PW, Fletcher CV. Counterpoint: let's expand the formulary system and renew its vigor. Am J Hosp Pharm 1986;43:2835.Google Scholar
  22. 22.
    Rucker TD. Micro/macro strategies for improving formulary performance. Clin Res Pract Drug Reg Affairs 1984;2:295–312.Google Scholar
  23. 23.
    Brooks PM, Jones J, Lawrence R, Ali R. Reducing the pill swill: an audit of clinical pharmacy. Med J Aust 1977;2:427–8.PubMedGoogle Scholar
  24. 24.
    Rucker TD. Drug utilization review: In: Morgan JP, Kagan DV, eds. Society and medication: conflicting signals. Lexington: Lexington Books, 1983:25–51.Google Scholar
  25. 25.
    Hoffmann RP. The foremost dilemma in managing a hospital formulary. Hosp Pharm 1982;17:245.PubMedGoogle Scholar
  26. 26.
    Wertheimer AI. Quality control and drug utilization review. Pharm Weekbl [Sci] 1988;10:154–7.Google Scholar
  27. 27.
    American Society of Hospital Pharmacists. ASHP statements on the formulary system and pharmacy and therapeutics committee. Am J Hosp Pharm 1986;43:2839–42.Google Scholar
  28. 28.
    Sudds TW, Williams RR. The goals and functions of a P & T committee. Hosp Formul 1985;20:1163–74.PubMedGoogle Scholar
  29. 29.
    Abramowitz PW, Godwin HN, Latiolais CJ, et al. Developing an effective P & T committee. Hosp Form 1985;20:827–47, 1071–88.Google Scholar
  30. 30.
    Rucker TD. Effective formulary development — which direction? Top Hosp Pharm Management 1981;1:40.Google Scholar
  31. 31.
    Lipman AG, Neu HC, Singh BN, Weintraub M. Editor's roundtable: current formulas for P & T committee success. Hosp Formul 1987;22:288–98, 373–82.PubMedGoogle Scholar
  32. 32.
    Kleinmann K. The importance of strong leadership. Hosp Formul 1977;12:117–9.PubMedGoogle Scholar
  33. 33.
    Kelly WN, Bender FH. Implementing and maintaining a viable formulary. Hosp Formul 1983;18:977–82.Google Scholar
  34. 34.
    Majerick PL, May JR, Longe RL, Johnson MH. Evaluation of pharmacy and therapeutics committee drug evaluation reports. Am J Hosp Pharm 1985;42:1073–6.PubMedGoogle Scholar
  35. 35.
    Lemay AP, Salzer LB, Visconti JA, Latiolais CJ. Strategies for deleting popular drugs from a hospital formulary. Am J Hosp Pharm 1981;38:506–10.PubMedGoogle Scholar
  36. 36.
    Zilz D. Total medical staff participation in formulary revision. Drug Intell Clin Pharm 1975;9:596–600.PubMedGoogle Scholar
  37. 37.
    Linkewich JA, Prevonik SJ. Guidelines on the operation of the pharmacy and therapeutics committee and formulary. Hosp Pharm 1979;14:7–22.PubMedGoogle Scholar
  38. 38.
    Roberts MJ, Summerfield MR. Formulary management to reduce cost: P & T committee strategies. Hosp Formul 1986;21:481–92.PubMedGoogle Scholar
  39. 39.
    Hassan WE. Hospital Pharmacy. Philadelphia: Lea & Febiger, 1986:138.Google Scholar
  40. 40.
    Lasagna L. Consensus among experts: the unholy grail. Persp Biol Med 1976;19:537–48.Google Scholar
  41. 41.
    Senthilkumaran K, Shatz SM, Kalies RF. Computerbased support system for formulary decisions. Am J Hosp Pharm 1987;44:1362–6.PubMedGoogle Scholar
  42. 42.
    Sesin GP. Therapeutic decision-making: a model for formulary evaluation. Drug Intell Clin Pharm 1986;20:581–3.PubMedGoogle Scholar
  43. 43.
    Bakke OM. How many drugs do we need? World Health Forum 1986;7:255.Google Scholar
  44. 44.
    Rucker TD. Superior hospital formularies: a critical analysis. Hosp Pharm 1982;17:467–512.Google Scholar
  45. 45.
    Rucker TD. Drug information: findings from a major study of formularies. Drug Inf J 1979;13:41–5.PubMedGoogle Scholar
  46. 46.
    Sateren LA, Sudds TW, Tyler LS. Computer-based system for maintaining and printing a hospital formulary. Am J Hosp Pharm 1987;44:1367–70.PubMedGoogle Scholar
  47. 47.
    Rucker TD. Formulary management—a macro strategy. Hosp Charm 1983;18:136.Google Scholar
  48. 48.
    Lipman AG. Dealing with ‘me-too’ drugs. Hosp Formul 1987;22:693.Google Scholar

Copyright information

© Royal Dutch Association for Advancement of Pharmacy 1988

Authors and Affiliations

  • T. Donald Rucker
    • 1
  1. 1.College of Pharmacy-UIC m/c 871ChicagoUSA

Personalised recommendations